Literature DB >> 35662493

Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer.

Hossein Jadvar1, Patrick M Colletti2.   

Abstract

Hormonal therapy has long been recognized as a mainstay treatment for prostate cancer. New generation imaging agents have provided unprecedented opportunities at all phases along the natural history of prostate cancer. We review the literature on the effect of androgens and androgen deprivation therapy on prostate tumor at its various biological phases using the new generation molecular imaging agents in conjunction with positron emission tomography.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen; Choline; FDG; Fluciclovine; Hormone; Imaging; PSMA; Prostate

Mesh：

Substances：

Year:  2022        PMID： 35662493      PMCID： PMC9232915          DOI： 10.1016/j.cpet.2022.02.003

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  64 in total

1.  10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients.

Authors:  Fabio Zattoni; Ilaria Ravelli; Marco Rensi; Decio Capobianco; Eugenio Borsatti; Tania Baresic; Agostino Chiaravalloti; Orazio Schillaci; Pierpaolo Alongi; Tommaso Vincenzo Bartolotta; Ilaria Rambaldi; Mirco Bartolomei; Mohsen Farsad; Manuel Tredici; Davide Donner; Franca Chierichetti; Giuseppe Trifirò; Elisabetta Brugola; Marta Burei; Fabrizio Dal Moro; Diego Cecchin; Laura Evangelista
Journal:  Clin Nucl Med       Date:  2020-08       Impact factor: 7.794

2.  Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.

Authors:  Rutger J Dost; Andor W J M Glaudemans; Anthonius J Breeuwsma; Igle J de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

3.  Diagnostic value of 18F-FDG PET/CT in patients with biochemical recurrent prostate cancer and negative 68Ga-PSMA PET/CT.

Authors:  Ruohua Chen; Yining Wang; Yiping Shi; Yinjie Zhu; Lian Xu; Gang Huang; Jianjun Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-02       Impact factor: 9.236

4.  Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.

Authors:  Sofia Vaz; Boris Hadaschik; Michael Gabriel; Ken Herrmann; Matthias Eiber; Durval Costa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01       Impact factor: 9.236

5.  Glucose metabolism of human prostate cancer mouse xenografts.

Authors:  Hossein Jadvar; Li Xiankui; Antranik Shahinian; Ryan Park; Michel Tohme; Jacek Pinski; Peter S Conti
Journal:  Mol Imaging       Date:  2005 Apr-Jun       Impact factor: 4.488

6.  Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.

Authors:  Edouard J Trabulsi; R Bryan Rumble; Hossein Jadvar; Thomas Hope; Martin Pomper; Baris Turkbey; Andrew B Rosenkrantz; Sadhna Verma; Daniel J Margolis; Adam Froemming; Aytekin Oto; Andrei Purysko; Matthew I Milowsky; Heinz-Peter Schlemmer; Matthias Eiber; Michael J Morris; Peter L Choyke; Anwar Padhani; Jorge Oldan; Stefano Fanti; Suneil Jain; Peter A Pinto; Kirk A Keegan; Christopher R Porter; Jonathan A Coleman; Glenn S Bauman; Ashesh B Jani; Jeffrey M Kamradt; Westley Sholes; H Alberto Vargas
Journal:  J Clin Oncol       Date:  2020-01-15       Impact factor: 44.544

Review 7.  18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis.

Authors:  Giuseppina Biscontini; Cinzia Romagnolo; Chiara Cottignoli; Andrea Palucci; Fabio Massimo Fringuelli; Carmelo Caldarella; Francesco Ceci; Luca Burroni
Journal:  Diagnostics (Basel)       Date:  2021-02-13

8.  Utility of 18F-Fluciclovine PET/MRI for Staging Newly Diagnosed High-Risk Prostate Cancer and Evaluating Response to Initial Androgen Deprivation Therapy: A Prospective Single-Arm Pilot Study.

Authors:  Samuel J Galgano; Andrew M McDonald; Soroush Rais-Bahrami; Kristin K Porter; Gagandeep Choudhary; Constantine Burgan; Pradeep Bhambhvani; Jeffrey W Nix; Desiree E Morgan; Yufeng Li; John V Thomas; Jonathan McConathy
Journal:  AJR Am J Roentgenol       Date:  2020-10-14       Impact factor: 6.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.